Avantax Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $541K | Buy |
|
|||||
|
2025
Q1 | $362K | Buy |
|
|||||
|
2024
Q4 | $269K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $234K | Sell |
|
|||||
|
2024
Q1 | $326K | Sell |
|
|||||
|
2023
Q4 | $341K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $305K | Buy |
|
|||||
|
2022
Q3 | $428K | Buy |
|
|||||
|
2022
Q2 | $391K | Buy |
|
|||||
|
2022
Q1 | $344K | Buy |
|
|||||
|
2021
Q4 | $348K | Buy |
|
|||||
|
2021
Q3 | $494K | Buy |
|
|||||
|
2021
Q2 | $620K | Buy |
|
|||||
|
2021
Q1 | $260K | Buy |
|